Optimization of Agrobacterium-mediated transformation and regeneration for CRISPR/Cas9 genome editing of commercial tomato cultivars

被引:7
|
作者
Secgin, Zafer [1 ]
Kavas, Musa [1 ]
Yildirim, Kubilay [2 ]
机构
[1] Ondokuz Mayis Univ, Fac Agr, Dept Agr Biotechnol, Samsun, Turkey
[2] Ondokuz Mayis Univ, Fac Arts & Sci, Dept Mol Biol & Genet, Samsun, Turkey
关键词
CRISPR; Cas9; genome editing; phytoene desaturase; plant regeneration; tomato; GENETIC-TRANSFORMATION; PLANT-REGENERATION; MICRO-TOM; PROTOCOL; PARAMETERS; EFFICIENCY;
D O I
10.3906/tar-2009-49
中图分类号
S [农业科学];
学科分类号
09 ;
摘要
Tomato (Solanum lycopersicum) is the second most important horticultural crop worldwide that is widely used as a model plant in genetic manipulation of Solanaceae. CRISPR/Cas9 system has been successfully utilized in several studies for genome edition of model tomato cultivars. However, these genome editing systems should be also optimized for commercial tomato cultivar for direct application of genome editing in field conditions. In this study, we have optimized an Agrobacterium-mediated gene transfer and regeneration system for CRISPR/Cas9 genome editing in two commercial tomato cultivars for the first time. The effect of explant type, genotype, pre-transformation time, Agrobacterium concentration, infection time, and different co-culture periods of bacteria were evaluated to optimize the regeneration and transformation parameters. The highest regeneration capacity of 83% was obtained from cotyledons of Crocker incubated in a medium supplemented with BA (3 mg/L) and IAA (0.1 mg/L). The maximum transformation frequency was obtained by using the following parameters: cotyledon explants of commercial Crocker cultivar that were left for 2 days of pre-transformation incubation, infected with Agrobacterium for 10 min at a concentration of OD600 of 0.6 and co-cultivated with Agrobacterium cells for 48 h. CRISPR/Cas9 system was tested with two gRNAs targeting the phytoene desaturase gene. Fully albino and chimeric plants were successfully produced with optimized transformation and culture conditions in up to 71% of all regenerated plants. In the current study, we optimized the implementation of the CRISPR/Cas9 technique in a commercial tomato cultivar and our method will enable breeders to make necessary changes in traits of interest to improve tomato crops for commercial applications.
引用
收藏
页码:704 / 716
页数:13
相关论文
共 50 条
  • [41] Nanoparticle Delivery of CRISPR/Cas9 for Genome Editing
    Duan, Li
    Ouyang, Kan
    Xu, Xiao
    Xu, Limei
    Wen, Caining
    Zhou, Xiaoying
    Qin, Zhuan
    Xu, Zhiyi
    Sun, Wei
    Liang, Yujie
    FRONTIERS IN GENETICS, 2021, 12
  • [42] Advances in therapeutic CRISPR/Cas9 genome editing
    Schwank, G.
    EUROPEAN JOURNAL OF HUMAN GENETICS, 2019, 27 : 1053 - 1053
  • [43] Efficient genetic transformation and genome editing via an Agrobacterium-mediated in commercial oat (Avena sativa L.) cultivars
    Shi, Kun
    Huang, Weihong
    Zhu, Mengxin
    Teng, Shouzhen
    Zhang, Jinli
    Duan, Zhizhen
    Zhu, Chenchen
    Hu, Tao
    Wang, Ke
    Wang, Zan
    JOURNAL OF INTEGRATIVE PLANT BIOLOGY, 2025,
  • [44] CRISPR/CAS9, the King of Genome Editing Tools
    Bannikov, A. V.
    Lavrov, A. V.
    MOLECULAR BIOLOGY, 2017, 51 (04) : 514 - 525
  • [45] CRISPR/CAS9: THE GOLD STANDARD OF GENOME EDITING?
    Gleeson, Alfie
    Sawyer, Abigail
    BIOTECHNIQUES, 2018, 64 (06) : 239 - 244
  • [46] CRISPR/Cas9 and other techniques for genome editing
    Hartung, Frank
    Schiemann, Jochen
    Sprink, Thorben
    ZWEITES SYMPOSIUM ZIERPFLANZENZUCHTUNG, 2017, 2017, 457 : 36 - 39
  • [47] Genome Editing in Cotton with the CRISPR/Cas9 System
    Gao, Wei
    Long, Lu
    Tian, Xinquan
    Xu, Fuchun
    Liu, Ji
    Singh, Prashant K.
    Botella, Jose R.
    Song, Chunpeng
    FRONTIERS IN PLANT SCIENCE, 2017, 8
  • [48] Advances in therapeutic CRISPR/Cas9 genome editing
    Savic, Natasa
    Schwank, Gerald
    TRANSLATIONAL RESEARCH, 2016, 168 : 15 - 21
  • [49] A glance at genome editing with CRISPR–Cas9 technology
    Antara Barman
    Bornali Deb
    Supriyo Chakraborty
    Current Genetics, 2020, 66 : 447 - 462
  • [50] Translating CRISPR/Cas9 genome editing into therapeutics
    Barnes, T. M.
    HUMAN GENE THERAPY, 2016, 27 (11) : A140 - A141